Jin Medical International Ltd. (ZJYL)

Jin Medical International Income Statement

Financials in millions USD. Fiscal year is October - September.

Year	2022	2021
Revenue	19.19	20.76
Revenue Growth (YoY)	-7.58%	-
Cost of Revenue	25.98	25.1
Gross Profit	-6.79	-4.33
Selling, General & Admin	2.18	2.16
Research & Development	1.89	1.57
Operating Expenses	4.07	3.73
Operating Income	-10.86	-8.06
Interest Expense / Income	-0.18	0.01
Other Expense / Income	-13.42	-10.95
Pretax Income	2.74	2.88
Income Tax	0.04	0.25
Net Income	2.71	2.63
Net Income Growth	2.84%	-
Shares Outstanding (Basic)	135	135
Shares Outstanding (Diluted)	135	135
EPS (Basic)	0.02	0.02
EPS (Diluted)	0.02	0.02
EPS Growth	5.26%	-
Free Cash Flow	1.54	5.8
Free Cash Flow Per Share	0.01	0.04
Gross Margin	-35.40%	-20.87%
Operating Margin	-56.60%	-38.84%
Profit Margin	14.10%	12.67%
Free Cash Flow Margin	8.03%	27.93%
Effective Tax Rate	1.32%	8.63%
EBITDA	2.92	3.24
EBITDA Margin	15.23%	15.59%
Depreciation & Amortization	0.36	0.35
EBIT	2.56	2.89
EBIT Margin	13.35%	13.92%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).